Filing Details
- Accession Number:
- 0001181431-11-047354
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-08-29 19:11:51
- Reporting Period:
- 2011-08-25
- Filing Date:
- 2011-08-29
- Accepted Time:
- 2011-08-29 19:11:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
820096 | Perrigo Co | PRGO | Pharmaceutical Preparations (2834) | 382799573 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1267878 | W Todd Kingma | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | Executive Vp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-08-25 | 8,901 | $90.94 | 28,056 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-08-25 | 3,632 | $90.94 | 24,424 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2011-08-25 | 5,598 | $90.94 | 30,022 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-08-25 | 2,284 | $90.94 | 27,738 | No | 4 | F | Direct | |
Common Stock | Disposition | 2011-08-26 | 1,600 | $88.65 | 26,138 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-08-26 | 2,100 | $89.47 | 24,038 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-08-26 | 1,800 | $90.45 | 22,238 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-08-26 | 500 | $91.25 | 21,738 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Disposition | 2011-08-25 | 8,901 | $0.00 | 8,901 | $0.00 |
Common Stock | Restricted Stock Units | Disposition | 2011-08-25 | 5,598 | $0.00 | 5,598 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2011-08-25 | 2011-08-25 | No | 4 | M | Direct |
0 | 2011-08-25 | 2011-08-25 | No | 4 | M | Direct |
Footnotes
- Vesting of Performance-based Restricted Stock Units granted on August 25, 2008.
- Vesting of Restricted Stock Units granted on August 25, 2008.
- This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 5, 2011. This 10b5-1 plan will expire on the close of business May 15, 2012.
- The price in column 4 is a weighted average. The prices actually received ranged from $88.03 to $89.03. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- The price in column 4 is a weighted average. The prices actually received ranged from $89.05 to $90.03. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- The price in column 4 is a weighted average. The prices actually received ranged from $90.08 to $90.81. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- The price in column 4 is a weighted average. The prices actually received ranged from $91.12 to $91.30. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.